Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

S E Nielsen; K J Schjoedt; A S Astrup; Lise Tarnow; Marianne Lajer; P R Hansen; H-H Parving; Pia Rossing

doi:10.1111/j.1464-5491.2010.03083.x

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

S E Nielsen
, K J Schjoedt
, A S Astrup
, Lise Tarnow
, Marianne Lajer
, P R Hansen
, H-H Parving
, Pia Rossing

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

Originalsprog	Engelsk
Tidsskrift	Diabetic Medicine
Vol/bind	27
Udgave nummer	10
Sider (fra-til)	1144-50
Antal sider	7
ISSN	0742-3071
DOI	https://doi.org/10.1111/j.1464-5491.2010.03083.x
Status	Udgivet - 1 okt. 2010

Adgang til dokumentet

10.1111/j.1464-5491.2010.03083.x

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Nielsen, S. E., Schjoedt, K. J., Astrup, A. S., Tarnow, L., Lajer, M., Hansen, P. R., Parving, H.-H., & Rossing, P. (2010). Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabetic Medicine, 27(10), 1144-50. https://doi.org/10.1111/j.1464-5491.2010.03083.x

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. / Nielsen, S E; Schjoedt, K J; Astrup, A S et al.
I: Diabetic Medicine, Bind 27, Nr. 10, 01.10.2010, s. 1144-50.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Nielsen, SE, Schjoedt, KJ, Astrup, AS, Tarnow, L, Lajer, M, Hansen, PR, Parving, H-H & Rossing, P 2010, 'Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril', Diabetic Medicine, bind 27, nr. 10, s. 1144-50. https://doi.org/10.1111/j.1464-5491.2010.03083.x

@article{aa9cdfa0ad5a4513b3fb6101aa9a6fd5,

title = "Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril",

abstract = "Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.",

author = "Nielsen, \{S E\} and Schjoedt, \{K J\} and Astrup, \{A S\} and Lise Tarnow and Marianne Lajer and Hansen, \{P R\} and H-H Parving and Pia Rossing",

note = "{\textcopyright} 2010 The Authors. Diabetic Medicine {\textcopyright} 2010 Diabetes UK.",

year = "2010",

month = oct,

day = "1",

doi = "10.1111/j.1464-5491.2010.03083.x",

language = "English",

volume = "27",

pages = "1144--50",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

AU - Nielsen, S E

AU - Schjoedt, K J

AU - Astrup, A S

AU - Tarnow, Lise

AU - Lajer, Marianne

AU - Hansen, P R

AU - Parving, H-H

AU - Rossing, Pia

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

AB - Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

U2 - 10.1111/j.1464-5491.2010.03083.x

DO - 10.1111/j.1464-5491.2010.03083.x

M3 - Journal article

SN - 0742-3071

VL - 27

SP - 1144

EP - 1150

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 10

ER -